Table 2.
Recurrent mutations and deletions identified during persistent SARS-CoV-2 infections
| Gene | Mutation | n | Lineage | Description |
|---|---|---|---|---|
| S | T547K | 2 | BA.2 | Lineage-defining for BA.1 |
| S | L452R | 2 | BA.2 | Lineage-defining for Delta and BA.4/5a |
| S | T376A | 2 | BA.1 | Lineage-defining for BA.2/4/5 |
| S | T95I | 1 | BA.2 | Lineage-defining for BA.1a |
| S | G446V/D | 2 | Delta and BA.2 | Target for monoclonal antibodies |
| S | D215G | 1 | BA.2 | Lineage-defining for Betaa |
| S | ΔA243/L244 | 3 | Alpha and BA.2 | Lineage-defining for Betaa |
| S | ΔY144 | 1 | BA.2 | Lineage-defining for Alpha and BA.1 |
| ORF1ab | L5905F | 2 | BA.1 and BA.2 | Commonly found in Mu and Delta |
| ORF1ab | T4175I | 2 | BA.1 | Commonly found in BA.2 |
| ORF1ab | T1638I | 2 | BA.2 | a |
| ORF1ab | D4532D | 1 | BA.2 | a |
| ORF1ab | Δ81–86 | 12 | Delta, BA.1 and BA.2 | a |
| ORF8 | I121L | 1 | BA.1 | a |
See Source Data Fig. 2 for more information about all mutations. Δ, deletion. aRecurrent in immunocompromised patients.